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https://doi.org/10.1002/nbm.3768Acetate has been proposed as an astrocyte‐specific energy substrate for metabolic studies in
the brain. The determination of the relative contribution of the intracellular and extracellular
compartments to the acetate signal using diffusion‐weighted magnetic resonance spectroscopy
can provide an insight into the cellular environment and distribution volume of acetate in the
brain. In the present study, localized 1H nuclear magnetic resonance (NMR) spectroscopy
employing a diffusion‐weighted stimulated echo acquisition mode (STEAM) sequence at an
ultra‐high magnetic field (14.1 T) was used to investigate the diffusivity characteristics of
acetate and N‐acetylaspartate (NAA) in the rat brain in vivo during prolonged acetate infusion.
The persistence of the acetate resonance in 1H spectra acquired at very large diffusion
weighting indicated restricted diffusion of acetate and was attributed to intracellular spaces.
However, the significantly greater diffusion of acetate relative to NAA suggests that a substantial
fraction of acetate is located in the extracellular space of the brain. Assuming an even
distribution for acetate in intracellular and extracellular spaces, the diffusion properties of
acetate yielded a smaller volume of distribution for acetate relative to water and glucose in the
rat brain.
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Acetate has been proposed as an astrocyte‐specific energy substrate for the brain and is an attractive alternative to glucose for in vitro and in vivo
nuclear magnetic resonance (NMR) studies of brain metabolism.1-6 The uptake of infused labeled acetate by only a single cell type in the brain (glial
compartment) can simplify the modeling and increase the sensitivity of the measurement of the glutamate–glutamine cycle in the brain relative to
the use of glucose, which is taken up by both neuronal and glial compartments alike.
To take full advantage of the dynamic information available from in vivo 13C NMR spectroscopy and to perform dynamic metabolic modeling of
the tricarboxylic acid (TCA) cycle activity and glutamate/glutamine cycling, prior knowledge of the transport and uptake kinetics of infused acetate
across the blood–brain barrier is required. Quantitative measurement of acetate transport in the brain has often been performed by fitting the
measured NMR data to the Michaelis–Menten model which requires the knowledge of the distribution volume (Vd) of acetate in the brain.
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2 of 12 DEHGHANI ET AL.However, the distribution volume of acetate in the rat brain during prolonged acetate infusion is not known. To study the transport and uti-
lization of acetate in the rat brain, Deelchand et al.8 assumed the same distribution volume for acetate as for glucose (Vd = 0.77 mL/g),
whereas Patel et al.7 considered a smaller distribution volume for acetate, equal to 0.32 mL/g, based on the hypothesis that acetate is mainly
localized in glial cells (whereas glucose is found in glial and neuronal cells). The assumed value for Vd impacts on the reported parameters for
acetate transport kinetics. To our knowledge, the acetate distribution and relative partitioning into the intracellular and extracellular compart-
ments of the brain, measured using the non‐invasive NMR modality, has not been reported.
Most in vivo NMR spectroscopy modalities do not distinguish between intracellular and extracellular contributions and provide information
about the whole‐tissue properties, such as metabolite concentrations in intact tissue.1,9-12 However, this information is important for accurate
metabolic modeling. By measuring the translational displacement of metabolites in tissue and providing information about the cellular environ-
ment, diffusion‐weighted magnetic resonance spectroscopy (DW‐MRS) could help in this regard (for reviews, see Cao & Wu,13 Nicolay et al.14
and Ronen & Valette,15 and references therein). DW‐MRS can differentiate between the signal originating from intracellular and extracellular
compartments based on their different diffusion properties.16 Therefore, DW‐MRS is likely to yield insights into the distribution volume of ace-
tate in the rat brain.
1H DW‐MRS remains a very challenging technique from the perspective of the acquisition of robust and reproducible DW‐MRS data and
their subsequent processing and quantification. DW‐MRS contrast is based on the random translational displacement of a metabolite; there-
fore, any type of bulk motion could result in amplitude or phase fluctuation of the NMR signal. The influence of eddy currents on the spectral
line shape is not particular to DW‐MRS, but the application of strong diffusion‐encoding gradient pulses significantly increases their effect. In
diffusion measurements, it is important to note that all the gradient operations in the pulse sequence should be taken into account when esti-
mating the diffusion weighting strength (b‐value), including the slice selection and crusher gradients as well as the main diffusion‐encoding
gradients.
A few studies have used DW‐MRS to assess the diffusion properties of metabolites in the rat brain in vivo.17-22 Most studies have
focused on the diffusion properties of particularly abundant metabolites, such as N‐acetylaspartate (NAA), which are predominantly located
in the intracellular compartment. Pfeuffer et al.23 performed a DW‐MRS study to test the hypothesis predicting a uniform distribution of
infused glucose in the extracellular and intracellular spaces of the rat brain, and characterized the diffusion properties of 14 metabolites.
The application of a similar strategy, 1H DW‐MRS of brain acetate under prolonged acetate infusion, could also provide information on
the intrinsic diffusion properties of acetate in the brain and yield an insight into the cellular compartments that constrain its diffusional
displacement.
The overlapping of metabolite resonances in in vivo spectra complicates the quantification of each individual metabolite. The challenge in the
study of acetate diffusion behavior is the overlap of the acetate 1H–MRS resonance (1.90 ppm) with a γ‐aminobutyric acid (GABA) resonance at
1.89 ppm, which hinders an accurate estimation of the concentration and diffusivity of acetate. Therefore, the purpose of this study was to address
the diffusion characteristics of acetate in the rat brain in vivo using DW‐MRS techniques at steady‐state concentration, whilst minimizing the
contribution of the overlapping GABA resonance.2 | METHODS
2.1 | Animal preparation
All experimental procedures involving animals were approved by the local veterinary authorities. Seven male Sprague–Dawley rats (200–235 g
delivered from Charles River Laboratories, L'Arbresle Cedex, France) were prepared without fasting. Animals were intubated and ventilated
with 2% isoflurane during surgery. Both femoral veins were catheterized for the administration of acetate and α‐chloralose. Two arteries were
cannulated for the continuous monitoring of physiology (blood pressure and heart rate) and periodic blood sampling for blood gas, plasma
lactate and glucose concentration measurements. Following surgery, anesthesia was switched to intravenous α‐chloralose administration (bolus
of 80 mg/kg and continuous infusion rate of 26.7 mg/kg/h). Animals were placed in a home‐built holder and the head position was fixed
using ear rods and a bite‐bar. The body temperature was maintained between 37.0 and 38°C with a temperature‐regulated circulating water
bath.2.2 | Acetate infusion protocol
The sodium acetate infusion protocol was optimized on the bench and in the magnet to reach a steady‐state concentration of acetate in the rat
brain in less than 30 min, whilst keeping the animal within physiological limits throughout the study. After the adjustment of MRS parameters
and shimming, a bolus of 1 g/kg of sodium acetate (1.6 M) was administered with an infusion rate decaying in a two‐step process over 10 min
(Figure 1). This bolus was followed by a continuous infusion of acetate at a rate of 1.4 g/kg/h.
In order to avoid metabolic alkalosis in the blood of animals during the study,24,25 the acetate solution was infused at an acidic pH (pH 5.0) as
used previously in rats.8,26
FIGURE 2 Diffusion‐weighted magnetic resonance spectroscopy (DW‐MRS) region of interest, with a size of 6 × 10 × 4 mm3, overlapped on axial
images of the rat brain. Images acquired using fast spin echo multiple slice [field of view (FOV), 25 × 25 mm2; slice thickness, 0.5 mm; average, 4;
data matrix, 128 × 128] at 14.1 T
FIGURE 1 (a) optimized acetate infusion protocol in the rat used to obtain a stable acetate concentration in the brain after 30 min. (B) time course
of acetate concentration in the brain [measured from in vivo 1H nuclear magnetic resonance (NMR) spectra at 14.1 T) following continuous
intravenous acetate infusion in the rat. Each time point and its error bars present the average and standard deviation of seven animals, estimated by
interpolation between the measured time points
DEHGHANI ET AL. 3 of 122.3 | In vivo and in vitro NMR spectroscopy at 14.1 T
Spectra were acquired on a 14.1‐TMRI system interfaced to a 26‐cm horizontal bore magnet (Magnex Scientific, Oxford, UK; Varian, Palo Alto, CA,
USA), equipped with an actively shielded gradient (inner diameter, 12 cm) reaching 400 mT/m in 120 μs. A home‐built quadrature transceiver with
two physically decoupled 12‐mm‐diameter loops was used.
After initial setting, fast spin echo images [TR = 4 s and effective echo time (TE) = 40 ms; four echoes] were acquired to select a volume of
interest (VOI) of 450 μL in the rat brain (Figure 2). Magnetic field homogeneity was adjusted using FAST(EST)MAP.27 Localized 1H NMR spectra
were acquired using the stimulated echo acquisition mode (STEAM) sequence.23 Acquisition parameters were optimized for acetate detection
and are described further below.
Water suppression was achieved with seven consecutive chemical shift‐selective (CHESS) adiabatic radiofrequency (RF)
pulses followed by crusher gradients. Outer volume suppression was performed using eight adiabatic pulses followed by crusher gradi-
ents, which were repeated three times during the CHESS preparation to minimize the unwanted signal. One spectrum was acquired
with the same VOI, but without application of water suppression, in order to provide a signal reference for quantification of the
metabolites.
4 of 12 DEHGHANI ET AL.2.4 | Accurate detection and quantification of acetate in 1H NMR spectra
To distinguish the overlapping acetate 1H MRS resonance (1.90 ppm) from the GABA resonance at 1.89 ppm, the rationale was to minimize the
GABA signal by playing with J modulation, enabling accurate acetate concentration quantification. As J modulation is affected by both TE and
mixing time (TM) in the STEAM sequence, a series of experiments was implemented to establish the optimum acquisition parameters. Experiments
were performed in a phantom containing 50 mM GABA (Sigma‐Aldrich, Shanghai, China) and 50mM NAA (Sigma‐Aldrich, Milan, Italy) as a refer-
ence with pH adjusted to 7.2 and a temperature of 37.5°C in order to mimic in vivo conditions. Spectra were initially acquired withTE ranging from
2.8 to 100 ms. With the optimum TE determined by the minimum amplitude of the GABA resonance at 1.89 ppm, a second series of data was
acquired withTM ranging from 24 to 174 ms. The optimumTM and TE values for the minimization of the GABA peak in phantom experiments were
evaluated in in vivo experiments in the rat brain.2.5 | Diffusion weighting acquisition parameters
The diffusion‐weighted STEAM (DW‐STEAM) sequence described by Pfeuffer et al.23 and Kunz et al.28 was used to investigate the metabolite
diffusivity characteristics in vivo in the brain of seven adult rats. Diffusion gradients are placed during the time delay τ in the STEAM sequence:
90°–τ–90°–TM–90°–τ–ACQ. The signal attenuation of the 1H diffusion is determined by the following acquisition parameters: diffusion gradient
amplitude Gdiff, duration of the applied diffusion gradients δ and separation of the diffusion gradients Δ, which define the diffusion time tD = Δ ‐ δ/3
and give rise to a b‐value of b = (γ2·G2·δ2)·tD. All of the gradient pulses, including both diffusion and STEAM gradients, were considered in the
b‐value calculation using a home‐built Matlab script (The MathWorks, Natick, MA, USA). Diffusion gradients were applied in three orthogonal
directions simultaneously in order to reach higher diffusion weighting. To vary the diffusion weighting of the signal in this study, only the
diffusion gradient amplitude was changed, whereas the other parameters were kept constant.
To test the performance of the DW‐STEAM sequence with the acquisition parameters optimized for the in vivo detection of acetate (as
described in Section 3.1), the attenuation of the signal from a high‐viscosity phantom containing 1,2‐propanediol (Sigma‐Aldrich, Buchs SG,
Switzerland) at room temperature (around 20°C) was measured by increasing the b‐value up to 18 ms/μm2.
In a first set of experiments, in vivo data were acquired with Gdiff = 0, 28, 49, 65 and 91 mT/m, corresponding to b‐values ranging from 0.2 to
5 ms/μm2. A second set of experiments to investigate the slow diffusion regime used three additional diffusion gradient amplitudes with stronger
intensities of 137, 159 and 191 mT/m and corresponding b‐values of 10, 13 and 18 ms/μm2. In all experiments, the signals were acquired with
δ = 5 ms, tD = 73 ms, TR = 4 s, and optimumTM and TE found to minimize the GABA resonance at 1.89 ppm in the STEAM sequence (as described
in Section 3.1).
The DW‐STEAM sequence was synchronized with the rat's breathing cycle with a respiration trigger in order to reduce the phase variation
between the averaged free induction decays (FIDs) caused by movement, and the data of each scan were stored separately to allow the phase
correction of individual spectra prior to averaging. To minimize the biasing effect of the attenuated spectral signals as a result of minor variations
in physiology, acetate concentration, shimming or spectral quality during the experiment, the acquisition over the entire b‐value range (0–18 ms/
μm2) for every animal was split into a series of acquisition sets with interleaved b‐values. The number of replicate scans in every set was 16 FIDs for
0 < b ≤ 5 ms/μm2 (each 1 min 5 s), 32 FIDs for b = 10 and 13 ms/μm2 (each 2 min 10 s) and 48 FIDs for b = 18 ms/μm2 (3 min 15 s).2.6 | Processing and quantification of the data
To prepare the acquired spectra from individual animals for analysis, the phase variations were corrected scan by scan by maximizing the NAA
resonance height; then, the phased spectra acquired at the same b‐value were corrected for B0 drift and averaged together.
In vivo 1H NMR summed spectra were processed using LCModel (Stephen Provencher Inc., Oakville, ON, Canada) and the unsuppressed water
signal acquired from the same voxel was used as a reference for eddy current correction and determination of the apparent metabolite concentra-
tions. No baseline correction, zero filling or apodization functions were applied to the data prior to the quantification. The Cramér–Rao lower
bounds (CRLBs) calculated by LCModel were used as a measure of the reliability of the metabolite estimates.
The basis sets required by LCModel for spectral quantificationwere generated by simulations of all themetabolites detected in the spectra of the
rat brain during continuous intravenous acetate infusion. The metabolite signals were simulated using the NMRSCOPE B plugin in JMRUI (http://
www.jmrui.eu) with the appropriate chemical shift and J‐coupling patterns as described by Govindaraju et al.29,30 and STEAM sequence parameters
used in this study. To validate the J‐modulation characteristics of the simulated spectra, a series of in vitro experiments, using a phantom containing
50 mM glutamine (Sigma Aldrich, Saint‐Quentin‐Fallavier, France) and 25 mM creatine (Cr) (Sigma Aldrich, Buchs SG, Switzerland), was performed,
varyingTE from2.8 to 100mswith steps of 10ms or less (TM=20ms and TR= 10 s). Themacromolecule (MM) signalsweremeasured experimentally
in vivo in the rat brain with aTR of 4 s and the optimized values of TE and TM found for the accurate quantification of acetate (as described in Section
3.1). Themeasurement was performed by preceding the DW‐STEAM sequence with an inversion recovery (IR) as described by Kunz et al.28 IR with a
non‐selective, full‐passage, hyperbolic secant RF pulse and inversion time (TI) of 1 s provided the best suppression of the metabolite signal with the
acquisition parameters used in this study (data not shown). To attenuate the residual metabolite signal after IR, diffusion gradients with a strength of
300 mT/m were applied along the three orthogonal directions simultaneously, resulting in a b‐value of 41 ms/μm2.
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To allow comparison with previous in vivo diffusion studies of metabolites,22,23,31-33 apparent mono‐exponential diffusion coefficients (DAppmonoÞ of
metabolites were estimated. Data for NAA and acetate in a b‐value interval of 0–5 ms/μm2 were fitted with a mono‐exponential diffusion model
using the following equation, where S and S0 are the signal intensities with and without diffusion gradients, respectively:
S
S0
¼ exp −b:DAppmono
 
(1)
Diffusion‐weighted data were then analyzed over b‐values ranging from 0 to 18 ms/μm2 and fitted using the following bi‐exponential equation,
whereDAppfast andD
App
slow represent the apparent diffusion coefficients (ADCs) of the fast and slow decaying signal components of each metabolite and
pAppslow reflects the relative contribution of the slow component to the metabolite signal
23:
S
S0
¼ pAppslow: exp −b:DAppslow
 
þ 1−pAppslow
 
: exp −b:DAppfast
 
(2)
To determine the confidence intervals of the adjusted parameters, Monte Carlo simulations were performed with 500 artificial datasets gen-
erated based on the bootstrapping method.34 Curve fitting based on the Levenberg–Marquardt algorithm and further numerical procedures were
performed in Matlab using in‐house scripts. The extracellular fraction of acetate pextra0 Aceð Þ was estimated by the following equation23:
pextra0 Aceð Þ ¼ 1−pAppslow Aceð Þ: kintra þ 1ð Þ (3)
where kintra was determined from the contribution ratio of fast and slow components of a known intracellular metabolite, like NAA,
simplified as:
kintra ¼
pAppfast NAAð Þ
pAppslow NAAð Þ
; pAppfast NAAð Þ ¼ 1−pAppslow NAAð Þ (4)
kintra ¼ 1
pAppslow NAAð Þ
−1 (5)
3 | RESULTS
The main goal of the present study was to assess the acetate diffusion properties in vivo in brain tissue and to compare them with those of a
reference intracellular metabolite, NAA. To this end, the acetate infusion protocol and DW‐STEAM sequence parameters were optimized to ensure
a reliable assessment of the diffusion behavior at steady‐state acetate concentration in the rat brain.
3.1 | Apparent concentration of acetate in brain tissue
To minimize spectral signal loss as a result of macroscopic motion, respiration cycle triggering was applied during acquisition and each FID signal was
stored separately. The high quality and signal‐to‐noise ratio (SNR) of the acquired 1H spectra enabled us to apply phase correction to individual spectra
before signal averaging. The higher sensitivity provided using a surface coil at highmagnetic field (14.1 T) with efficientB0 shimming using the FAST(EST)
MAPmethod yielded a linewidth of 20–25Hz,27with a typical NAA singlet resonance SNRof 14 averaging 16 scans acquiredwith a voxel size of 240 μL.
To reduce the signal overlap between the acetate singlet and the GABA resonance at 1.89 ppm, a long TE of 50 ms and TM of 49 ms in the
STEAM sequence were used (Figure 3). This resulted in well‐resolved acetate resonance (1.90 ppm) in spatially localized 1H NMR spectra with
and without diffusion weighting (Figure 4 and Supplementary material). The NAA singlet SNR of the spectra used in this study was higher than
20 for all b‐values (0–18 ms/μm2) , which was sufficient for a precise quantification of the detected metabolites (CRLB ≤20).
To ensure detectable acetate concentrations, an optimized infusion protocol was used to raise brain acetate concentrations to measurable
levels, whilst maintaining the animal within physiological limits throughout the study. The acetate concentration time course in the rat brain
reached steady state in less than 30 min (Figure 1). Brain acetate concentration during continuous intravenous acetate infusion reached 3.5 mM
(±20%) at steady state (Figure 1), estimated after correction for T1 and T2 relaxation of the signal.
35
3.2 | Diffusion‐weighted 1H MRS
The signal attenuation of 1,2‐propanediol was ascertained to be mono‐exponential with b‐values ranging from 0 to 18 ms/μm2, and its self‐diffusion
coefficient (Dfree) at room temperature (around 20 °C) was about 0.32 ± 0.07 μm
2/ms, close to the value reported in a recent study,36 demonstrating
the reliability of the procedure used in this study.
FIGURE 3 In vivo 1H nuclear magnetic resonance (NMR) spectra of rat brain acquired using a stimulated echo acquisition mode (STEAM) sequence
(TR = 4 s and apodization = 5 Hz; average = 2 × 16) in the absence of acetate infusion at short echo time (TE = 8.5 ms and TM = 20 ms) (top) and
long echo time (TE = 50 ms and TM = 49 ms) (bottom). GABA‐H4 and GABA‐H2 indicate the triplet resonances at 3.01 and 2.28 ppm, and GABA‐
H3 corresponds to the quintet resonance centered at 1.89 ppm. The noticeable shoulder corresponding to the quintet resonance of GABA at
1.89 ppm was minimized at TE ~ 50 ms. Cr, creatine; GABA, γ‐aminobutyric acid; NAA, N‐acetylphosphate; PCr, phosphocreatine
FIGURE 4 The diffusion‐attenuated summed 1H nuclear magnetic resonance (NMR) spectra (TR = 4 s, TE = 50 ms, TM = 49 ms,
apodization = 5 Hz) acquired during stability of acetate concentration in the single rat brain. Every spectrum is the sum of a given number of spectra
(shown in parentheses) acquired at a specific b‐value. From top to bottom: 0.2 (4 × 16), 1 (4 × 16), 2 (4 × 16), 3 (4 × 16), 5 (4 × 16), 10 (4 × 32), 13
(4 × 32) and 18 (4 × 48) ms/μm2. Ace, acetate; Cr, creatine; NAA, N‐acetylphosphate; PCr, phosphocreatine
6 of 12 DEHGHANI ET AL.To compare the intrinsic diffusivity of acetate and NAA, the free diffusion of acetate and NAA was estimated in vitro in a phantom containing
acetate and NAA with b‐values ranging from 0 to 3.5 ms/μm2. A mono‐exponential fitting of the acquired DW signals resulted in a Dfree of
1.27 ± 0.03 μm2/ms for acetate and 0.83 ± 0.02 μm2/ms for NAA (Table 1). To determine the diffusivity of acetate and NAA for 2–3 h during
DEHGHANI ET AL. 7 of 12continuous intravenous acetate infusion in rat, diffusion‐attenuated spectra were acquired using the DW‐STEAM sequence with optimized param-
eters (TE = 50 ms and TM = 49 ms). With increasing diffusion weighting up to b = 5 ms/μm2 (Figure 4 and Supplementary material), the acetate
intensity dropped by 65% and NAA by 35% of their respective intensities without diffusion weighting. Fitting a mono‐exponential decay to the
normalized attenuated signal relative to the b‐value range (Figure 5) enabled the determination of anADCof 0.09μm2/ms forNAAand approximately
three times higher ADC for acetate, i.e. 0.24 μm2/ms, with a coefficient of variation lower than 5% (Table 1). When extending the measurement to
higher b‐values, the normalized diffusion‐attenuated signal for NAA and acetate was clearly non‐linear, indicating a multi‐exponential decay
(Figure 5). Increasing the diffusion weighting to higher b‐values up to 18 ms/μm2 resulted in signal attenuation of 83% for acetate and 63% for
NAA comparedwith their initial amplitude. At maximum b‐value, the NAA signal was still above the noise level of a single FID spectrum and themean
CRLBs estimated by LCModel for NAA and acetate quantification in summed spectra from a single animal were 2% and 10%, respectively. In addition,
other prominent brain metabolites, such as glutamate, taurine, Cr and phosphocreatine (PCr) (not addressed in this study), were well quantified with
CRLBs of less than 10%.
To characterize the non‐mono‐exponential decay of acetate and NAA, normalized attenuated metabolite signals were fitted using Equation 2
over the entire b‐value range (0–18 ms/μm2) in Figure 5. Bi‐exponential fitting provided ADCs for the fast and slow decaying components of the
acetate and NAA signals (Table 2). The fast diffusion component of acetate showed an ADC (DAppfast ) of 0.44 ± 0.02 μm
2/ms, whereas DAppfast of NAA
was 0.20 ± 0.04 μm2/ms. The slow diffusion component of acetate was characterized by an ADC (DAppslow) of 0.038 ± 0.003 μm
2/ms and, for NAA,
DAppslow was 0.026 ± 0.010 μm
2/ms. The probability distribution of the slow and fast diffusion of acetate and NAA (estimated from Monte Carlo
simulations, n = 500) is shown in Figure 6.
The contribution of the slow component to the normalized attenuated signal ( pAppslow ) was found to be 33 ± 2% for acetate and 58 ± 10% for NAA.
The intracellular component ratio kintra (Equation 5) was estimated from p
App
slow of NAA (0.72 ± 0.1) and used as a reference for metabolites localized
purely in the intracellular compartment. The extracellular fraction pextra0 for acetate (Equation 3) was estimated to be 43 ± 12%. Moreover, the
estimation ofpextra0 of acetate using p
App
slow of Cr + PCr instead of NAA yields a similar value of 39 ± 8% (data not shown), encompassing the same range.FIGURE 5 The normalized diffusion‐
attenuated 1H magnetic resonance
spectroscopy (MRS) signal intensities of
acetate (A) and N‐acetylaspartate (NAA) (B) in
rat brain in vivo, with mono‐exponential fitting
of the b‐value range of 0–5 ms/μm2 (broken
lines) and bi‐exponential fitting of the b‐value
range of 0–18 ms/μm2 (full lines) in the semi‐
logarithmic plot. The error bars indicate the
standard deviation of data averaged over
seven animals
TABLE 1 Apparent diffusion coefficient of metabolites estimated using a mono‐exponential fit in rat brain in vivo for 0 < b < 5 ms/μm2 and in
phantom for 0 < b < 3.5 ms/μm2 (mean ± standard deviation) calculated by Monte Carlo
DAppmono (μm
2/ms)
Ace NAA
In vivo 0.24 ± 0.008 0.086 ± 0.002
In phantom 1.27 ± 0.01 0.83 ± 0.01
Ace, acetate; NAA, N‐acetylaspartate.
TABLE 2 Apparent diffusion coefficients of metabolites in rat brain in vivo at 14.1 T estimated using a bi‐exponential fit for 0 < b < 18 ms/μm2
(mean ± standard deviation) calculated by Monte Carlo
Ace NAA
Dappfast(μm
2/ms) 0.44 ± 0.02 0.20 ± 0.04
Dappslow(μm
2/ms) 0.038 ± 0.003 0.026 ± 0.010
pappslow (%) 33 ± 2 58 ± 10
Ace, acetate; NAA, N‐acetylaspartate.
FIGURE 6 Monte Carlo probability distribution of the estimated parameters in the bi‐exponential model including the apparent diffusivity of the
fast component (a), apparent diffusivity of the slow component (B) and relative contribution of the slow component (C) in the total signal for
acetate (ace) and N‐acetylaspartate (NAA). Artificial datasets (n = 500) in the Monte Carlo method were generated based on the bootstrapping
method, i.e. every artificial data point corresponds to the average of seven points generated by sampling from measured dataset with replacement
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Localized 1H NMR spectroscopy performed using a diffusion‐weighted STEAM sequence at ultra‐high magnetic field (14.1 T) allowed us to
investigate the diffusivity characteristics of acetate and NAA in the rat brain in vivo. The diffusion behavior of acetate was compared with that
of NAA, which is considered as a reference for the diffusivity characteristics of an exclusively intracellular metabolite. Observing the acetate
signal at very high b‐values implies the restriction of some part of the acetate signal to the intracellular space. The most notable result of the
present work is the observation of significantly higher ADCs for acetate compared with NAA over the studied b‐value range. The diffusion
characteristics of acetate provide insight into the distribution volume of acetate in the rat brain.4.1 | Precise quantification of acetate in the rat brain in vivo
Acetate is present in brain tissue at concentrations too low to be consistently detectable by 1H NMR in vivo, even at 14.1 T, for the measurement of
acetate transport across the blood–brain barrier and dynamic 13C MRS of labeled acetate.1,8 The infusion protocol was optimized to provide a
stable acetate concentration in vivo for extended time periods, which reached a readily detectable steady‐state level of 3–4 mM (Figure 1).
The challenge to establish the reliable measurement of acetate diffusivity was to minimize the GABA resonance at 1.89 ppm which could
interfere with the quantification of the acetate resonance, particularly at high diffusion weighting, as GABA is larger and less mobile than acetate.
GABA has six NMR‐observable protons in three methylene groups, forming an A2M2X2 spin system. The triplet resonances for GABA‐H4 and
GABA‐H2 appear at 3.01 and 2.28 ppm, respectively, whereas the GABA‐H3 quintet is centered at 1.89 ppm and thus overlaps with acetate. The
acetate methyl resonance is a singlet peak and does not undergo J‐coupling evolution, whereas the GABA resonance could be suppressed using
its unique J‐coupling properties at a specificTE and TM. Therefore, application of the optimal parameters in the DW‐STEAM sequence to minimize
the GABA peak at 1.89 ppm (TE = 50 ms and TM = 49 ms) allowed the quantification of acetate with minimal contamination from the GABA signal.
However, the application of a longTE during 1HMRS acquisition leads to substantial signal losses fromT2 relaxation and, accordingly, requires more
averaging to achieve sufficient SNR for quantification.
With aTE of 50 ms, CRLBs obtained from the LCModel quantification were lower than 10% for acetate and NAA in reference spectra, as well
as in all diffusion‐weighted spectra. The high precision of the estimated metabolite concentrations is ascribed to the high spectral resolution and
SNR of the 1H spectra acquired at 14.1 T and preprocessing to correct the phase and frequency drift of individual spectra before averaging and
quantification of the metabolite signal.
The acquisition parameters (TE and TR) used in this study result in T1 and T2 relaxation effects on quantification of the measured signals, and
this was taken into account and corrected using previously measured T1 and T2 relaxation times of the metabolites.
354.2 | Diffusion characteristics of acetate and NAA
To interpret the diffusivity of acetate without applying the assumptions used for diffusion data modeling (for reviews, see Cao & Wu,13 Nicolay
et al.14 and Ronen & Valette15), we compared it with the diffusion of NAA, as NAA is known to be an intracellular metabolite mostly confined
to neurons,37 and therefore could be used for comparison with the diffusion properties of other metabolites, where the cellular localization may
be less established. NAA is particularly suitable as a neuronal diffusion marker as it appears prominently in 1H spectra of the rat brain, with its main
singlet peak not subject to J modulation.
When considering a range of b‐values of 0–5 ms/μm2, a mono‐exponential decrease was observed, as judged from the linear decay for acetate
and NAA in vivo signals in a semi‐logarithmic plot (Figure 5). Furthermore, the application of respiration cycle triggering during 1H spectral acqui-
sition and single‐FID phase correction generally avoided signal loss and the related overestimation of the metabolite ADC.38 The consistency of the
estimated ADC of NAA using b‐values in the range 0–5 ms/μm2 with previous studies performed at longer diffusion times23,33 implied that the
DEHGHANI ET AL. 9 of 12diffusion time chosen in this study (73 ms) was long enough to place the diffusion signal decay of metabolites in the diffusion time independence
regime.21 However, the ADC of NAA has been reported with slightly higher values in some studies,22,31 which could be explained by the shorter
diffusion time used in these studies (10–20 ms). A shorter diffusion time implies a smaller mean displacement of metabolites, which limits the
interaction with the environment and increases the ADC.18,39 In addition, the lower metabolite ADC values reported here could be ascribed to
the higher magnetic field used (14.1 T) and the resulting higher sensitivity and spectral resolution.
Themost noteworthy result of the present study is the observation of an approximately three‐fold higherADCof acetate comparedwithNAA for
b‐values in the range 0–5ms/μm2. This difference cannot solely be accounted for by the smaller molecular size and larger free diffusion of acetate, as
its free ADCmeasured in a phantomwas only 1.5 times that of NAA's, indicating that acetate is in an environment with fewer barriers to its diffusion.
The bi‐exponential regression of normalized acetate and NAA signals over the b‐value range 0–18 ms/μm2 was characterized by fast and slow
diffusion components (DAppfast , D
App
slow ). The diffusion of the fast component of acetate was approximately two‐fold higher than that of NAA, as
observed in the mono‐exponential fitting of the acetate and NAA diffusion signal in the b‐value range 0–5 ms/μm2 (Tables 1 and 2).
DAppslow was determined for acetate with higher precision than for NAA (error of 10% for acetate and 40% for NAA). In our study, the rationale
was to choose a sufficiently large b‐value range for the study of the hindered diffusion of acetate. Fortunately, the fast diffusion component of
acetate decayed rapidly and its contribution at b‐values higher than 5 ms/μm2 was less than 11% and reached a negligible level of 0.03% at
18 ms/μm2. Therefore, the acquisition of spectra with a b‐value range of 0–18 ms/μm2 was sufficient to determine both fast and slow diffusion
components of acetate inside the brain for bi‐exponential modeling. However, the b‐value range of 0–18 ms/μm2 might not be sufficiently high
for a precise estimation of the slow component of NAA, and could thus result in an overestimation of the slow component.
The diffusion of acetate in the extracellular compartment is reflected mainly in the fast diffusion component, and its diffusion in the intracellular
compartment can probably be associated with the slow diffusion component. Considering DAppfast of acetate as 0.44 ms/μm
2, the contribution of the
extracellular signal to the total signal measured at a b‐value higher than 5ms/μm2was less than 10%. Therefore, the observed signal at b‐values higher
than 5ms/μm2 could be consideredmainly as the slow component, reflecting the slowdiffusing intracellular fraction ofmolecules.DAppslowof acetate and
NAAwas an order of magnitude lower than theirDAppfast , as reported for several metabolites in previous studies.
18,23,33 Themuch smaller values ofDAppslow
thanDAppfast demonstrate that intracellular barriers and restrictions dominate the diffusion of these metabolites at such high b‐values and long diffusion
times.
The percentage of the acetate signal at a b‐value of 18 ms/μm2 was 16% of the total signal, approximately two‐fold less than that observed for
NAA, namely 37%. The faster decay of the fast component of acetate diffusion relative to NAA and the lower contribution of the slow diffusion
component of acetate at high b‐values suggest that a significant part of the acetate signal arises from the extracellular compartment.4.3 | Evidence of acetate localization in glial cells
Acetate has been proposed as a potential glial marker because of its almost exclusive uptake in astrocytes.1,7,40 The estimatedDAppslow of acetate was
slightly higher than that of NAA in Table 2. However, at the diffusion time used in this study (73 ms), DAppslow of metabolites is expected to reflect
cellular dimensions rather than the respective molecule size. Slight differences in the estimated DAppslow for acetate and NAA may therefore suggest
a different cellular localization, such as inositol in astrocytes, where the differentDAppslow of acetate from a neuronal marker, NAA, could be attributed
to the different structure and shape of glial cytosol compared with neuronal cells. However, the difference between DAppslow of NAA and acetate did
not reach statistical significance and further investigations at substantially higher precision are indicated.
Interestingly, DAppslow for inositol (0.037 ± 0.003 μm
2/ms), reported by Pfeuffer et al.,23 is close to DAppslow of acetate. This similarity suggests that
acetate and inositol may share a similar intracellular distribution space, which is probably different from that of NAA. It has been proposed in
several studies using different measurement techniques that acetate and inositol are both located mainly in glial cells.3,40-434.4 | Distribution volume of acetate in rat brain tissue
The extracellular fraction of the acetate signal in the brain was estimated to be 43 ± 12% under the experimental conditions of the present study, i.e.
continuous intravenous acetate infusion in the rat. The contribution of the acetate signal from cerebrospinal fluid and blood was assumed to be neg-
ligible because of the rapid signal loss at low b‐values (free diffusion of acetate, 1.27 ± 0.01 μm2/ms). The estimated extracellular fraction of
the acetate signal, 43%, is greater than two‐fold the reported value for the extracellular fraction of glucose (17%).23 Therefore, the difference in
extracellular fraction of acetate and glucose implies a distribution of acetate distinctly different from the uniform brain glucose distribution. In other
words, the intracellular and extracellular signals have approximately equal contributions to the total detected acetate signal.
After passing the blood–brain barrier, acetate will enter the intracellular or extracellular space, and may be either uniformly or unequally
distributed between these compartments. Based on the results of this study, 43% of the acetate signal is assigned to the extracellular space, a region
occupying approximately 20% of the volume of thewhole brain.44 Assuming identical acetate concentrations in the extracellular compartment and in
the intracellular compartment in which acetate is localized, it follows that the intracellular fraction of acetate (57%) is in a cellular compartment occu-
pying approximately 27% of the brain, suggesting that acetate may not have access to the whole intracellular space, but rather to a subpopulation of
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cellular and/or intracellular space in the brain, is estimated to be 47%.
Alternatively, with its metabolic conversion, acetate may have a lower steady‐state concentration in the intracellular space com-
pared with the extracellular space. In this case, acetate will be distributed in a larger intracellular volume than that estimated above
assuming equal concentrations (27%) and, consequently, acetate in both astrocytes and neurons would contribute to the intracellular
signal. It is challenging to differentiate the concentration of acetate in different intracellular compartments because of the variable
expression of monocarboxylate transporter (MCT) isoforms in astrocytes and neurons.44 Nonetheless, this simplified assumption, of
an equal acetate concentration in neurons and astrocytes, would result in an extracellular acetate concentration three times the intra-
cellular level.
Although our data cannot exclude this possibility, we believe that the results are best explained by acetate having access to an intracellular
volume less than the whole intracellular space, which is consistent with acetate being a marker for glial metabolism as suggested in previous
studies.1,7,40 The lower estimated value of Vd for acetate in the rat brain is comparable with the acetate Vd value (32 ± 12%) reported by Patel et al.
7
in a study using 13C–acetate. There, a smaller Vd for acetate than for glucose was found to achieve better fitting of
13C–labeling time courses of
glutamate and glutamine, as well as the time course of acetate concentration in brain in a kinetic analysis of acetate transport and utilization across
the blood–brain barrier.
To acquire data in this study, the sequence parameters (e.g. TE and b‐value) were optimized for precise quantification and evaluation of the
diffusivity of acetate in the brain. Therefore, these parameters may not be optimal for the assessment of the diffusion behavior of other metabolites
in the brain, such as NAA.DAppfast andD
App
slowof NAA are determined with lower precision compared with acetate (cf. Figure 6) or with a previous study
by Pfeuffer et al.,23 where a much broader b‐value range of 0–50 ms/μm2 was used. The acquisition of spectra with sufficient SNR at a b‐value of
50 ms/μm2 requires more temporal averaging and results in a substantial increase in acquisition time.
The exchange of metabolites across the cell membrane could attenuate the intracellular diffusion signal, as has been reported for water
diffusion inside the cell.45 The transport of acetate across the cell membrane was assumed to have a minor impact on the intracellular attenuated
signal at the given diffusion time used in this study.5 | CONCLUSIONS
We conclude that the presence of acetate resonance in 1H spectra acquired at very large diffusion weighting indicates restricted diffusion of
acetate in the intracellular region of brain. The different behavior of the slow diffusion component of acetate in the intracellular space compared
with the neuronal marker NAA may suggest different intracellular localization for acetate in the brain, compared with NAA, most probably the glial
compartment. It remains a challenge to link the bi‐exponential model with the structure of compartments in the brain and the results should be
considered with more caution.
Finally, we propose that acetate probably occupies a different physical distribution space than water and some other metabolites, such as
glucose. The revised volume of distribution value of acetate may have a significant effect on the results and interpretations of acetate metabolism
in the normal brain, as well as in clinical and preclinical studies of diseases such as diabetes.
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